CIK 0002029039 · Non-accelerated filer<br>Emerging growth company
Nasus Pharma Ltd
Sign in to watch- Ticker
- NSRX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- EIN
- 516022712
- Phone
- 972 54-255-3956
- Business address
- 29 HARAKEVET ST, TEL AVIV - YAFO, Israel, 6618003
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- F-3 Offering F-3
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- CERT Other Certification
- 8-A12B Other Registration of Securities
- FWP Offering Free Writing Prospectus
- FWP Offering Free Writing Prospectus
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
Page 1 of 2 · 30 filings